nad has been researched along with Metabolic Syndrome in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 9 (69.23) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
Boutant, M; Canto, C; Cercillieux, A; Giner, MP; Giroud-Gerbetant, J; Joffraud, M; Kulkarni, SS; Moco, S; Ratajczak, J; Sambeat, A; Sanchez-Garcia, JL; Valera-Alberni, M; Valsesia, A | 1 |
Chelvanambi, S; Frump, AL; Hester, JM; Lahm, T; Sharma, S | 1 |
Boriek, AM; Pardo, PS | 1 |
Kumari, B; Yadav, UCS | 1 |
Brunner, M; Sancar, G | 1 |
Yan, LJ | 1 |
Borradaile, NM; Chan, P; Hughes-Large, JM; Pang, DK; Robson, DL; Toma, J | 1 |
Buzadzic, B; Daiber, A; Jankovic, A; Korac, A; Korac, B; Otasevic, V; Stancic, A | 1 |
Hoth, JJ; Liu, T; McCall, CE; Vachharajani, VT; Wang, X; Yoza, BK | 1 |
Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK | 1 |
Liang, Y; Vanhoutte, PM; Wang, Y; Xu, C | 1 |
Barbosa, MT; Capellini, V; Chini, EN; Escande, C; Gomes, AP; Nin, V; O'Neil, L; Price, NL; Sinclair, DA; White, TA | 1 |
7 review(s) available for nad and Metabolic Syndrome
Article | Year |
---|---|
SIRT1 Regulation in Ageing and Obesity.
Topics: Aging; Animals; Diabetes Mellitus, Type 2; DNA Damage; Exercise; Gene Expression Regulation; Humans; Hypoxia; Inflammation; Insulin Resistance; Metabolic Syndrome; Mice; NAD; Obesity; Oxidative Stress; Protein Domains; Protein Processing, Post-Translational; Risk; Sirtuin 1; Stress, Mechanical | 2020 |
Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.
Topics: Adipocytes; Adipokines; Adipose Tissue; Animals; Apoptosis; Biomarkers; Cytokines; Diabetes Mellitus; Disease Susceptibility; Glucose; Humans; Immunity; Metabolic Syndrome; Molecular Targeted Therapy; NAD; Nicotinamide Phosphoribosyltransferase; Signal Transduction | 2018 |
Circadian clocks and energy metabolism.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Circadian Clocks; Energy Metabolism; Gene Expression Regulation; Humans; Metabolic Syndrome; Models, Biological; NAD; Polymorphism, Genetic | 2014 |
Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.
Topics: Diabetes Mellitus, Type 2; Electron Transport; Glucose; Glycation End Products, Advanced; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycerophosphates; Humans; Hyperglycemia; Metabolic Syndrome; Mitochondria; NAD; Oxidative Stress; Protein Kinase C; Reactive Oxygen Species; Superoxides | 2014 |
Redox implications in adipose tissue (dys)function--A new look at old acquaintances.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Hydrogen Peroxide; Insulin Resistance; Metabolic Syndrome; Mitochondria; NAD; NADPH Oxidases; Obesity; Oxidation-Reduction | 2015 |
Sirtuins Link Inflammation and Metabolism.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Cardiovascular Diseases; Energy Metabolism; Gene Expression Regulation; Homeostasis; Humans; Inflammation; Metabolic Syndrome; NAD; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction; Sirtuins | 2016 |
SIRT1 in metabolic syndrome: where to target matters.
Topics: Aging; Animals; Cardiovascular Diseases; Exercise; Glucose; Humans; Lipid Metabolism; Metabolic Syndrome; Muscle, Skeletal; NAD; Organ Specificity; Protein Structure, Tertiary; Sirtuin 1 | 2012 |
6 other study(ies) available for nad and Metabolic Syndrome
Article | Year |
---|---|
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; DNA Damage; Gene Knockout Techniques; Genetic Predisposition to Disease; Glucose Intolerance; Hepatocytes; Insulin Resistance; Lipid Metabolism; Liver; Liver Diseases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Protective Agents; Pyridinium Compounds | 2019 |
Slide-Seq for Spatially Mapping Gene Expression. Metabolic Syndrome Exacerbates Group 2 Pulmonary Hypertension, and NAD Metabolism Is Influenced by Tissue Origin.
Topics: Gene Expression; Humans; Hypertension, Pulmonary; Metabolic Syndrome; NAD | 2020 |
Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity.
Topics: Animals; Aorta; Apoptosis; Cattle; Cell Death; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Drug Combinations; Endothelial Cells; Gene Expression Regulation; Humans; Immunohistochemistry; Laminin; Lipids; Metabolic Syndrome; Microcirculation; NAD; Niacin; Nicotinamide Mononucleotide; Obesity; Protein Binding; Proteoglycans; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic; RNA Interference; RNA, Small Interfering; Serum Albumin | 2014 |
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
Topics: Adenylate Kinase; Animals; Disease Models, Animal; Energy Metabolism; Metabolic Syndrome; Mice; Mice, Knockout; NAD; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Naphthoquinones; Obesity; Oxidation-Reduction; Phenotype; Signal Transduction | 2009 |
Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.
Topics: ADP-ribosyl Cyclase 1; Animals; Apigenin; Cell Line, Tumor; Gene Expression Regulation; Humans; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; NAD; Obesity; Quercetin; Random Allocation; Sirtuin 1 | 2013 |